The country's expanding middle class demonstrates willingness to pay for effective obesity treatment through private healthcare channels and international prescription services
Beyond safety, understanding how tirzepatide works in the real world, in diverse groups of people, including those with multiple health conditions or limited access to medical care, is crucial
GLP-1 receptor agonists and dual GLP-1/GIP medications like tirzepatide have shown menstrual irregularities in some patients, though the effect is typically tied to weight loss rather than the drug itself
Finally, we previously used an animal experiment to show that RGC loss in Nrf2 knockout mice was much faster after optic nerve damage was induced by crushing the nerve 41
Concerning long-term outcomes, extended AOM usage substantially enhanced results, as patients maintaining medication consistently demonstrated 14.70%-17.34% weight reduction versus merely 9.25%-12.56% with short-duration use